Clinical Trial Update: Cryoablation in Combination (or Not) With Pembrolizumab and Pemetrexed-carboplatin in 1st-line Treatment for Patients With Metastatic Lung Adenocarcinoma [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating whether adding cryoablation to first-line pembrolizumab plus pemetrexed–carboplatin improves outcomes in metastatic lung ade…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Adenocarcinoma

Drugs mentioned

• Alimta (pemetrexed)
• CARBOPLATIN (Carboplatin)
• KEYTRUDA (PEMBROLIZUMAB)

Snippet

Sponsor: Institut Bergonié | Conditions: Lung Adenocarcinoma, Cryotherapy Effect | Phase 3 | Status: RECRUITING